Amneal Pharmaceuticals (NasdaqGS:AMRX) Q2 2026 Earnings call July 30, 2026 08:30 AM ET Thank you. Good morning, everyone. Amneal is in the midst of the most transformative period in our company's history. We are growing as one of the America's leading affordable medicines businesses with an increasingly diversified and high-impact medicines portfolio, including Specialty brands, biosimilars, GLP-1s, and complex generics across dosage forms such as transdermals and injectables. As we execute our strategy, we ...